These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
168 related items for PubMed ID: 22036638
1. Follow-up of high-intensity focused ultrasound treatment for patients with hepatocellular carcinoma. Xu G, Luo G, He L, Li J, Shan H, Zhang R, Li Y, Gao X, Lin S, Wang G. Ultrasound Med Biol; 2011 Dec; 37(12):1993-9. PubMed ID: 22036638 [Abstract] [Full Text] [Related]
2. Short and long term efficacy of high intensity focused ultrasound therapy for advanced hepatocellular carcinoma. Li YY, Sha WH, Zhou YJ, Nie YQ. J Gastroenterol Hepatol; 2007 Dec; 22(12):2148-54. PubMed ID: 18031373 [Abstract] [Full Text] [Related]
3. High intensity focused ultrasound (HIFU) therapy for local treatment of hepatocellular carcinoma: role of partial rib resection. Zhu H, Zhou K, Zhang L, Jin C, Peng S, Yang W, Li K, Su H, Chen W, Bai J, Wu F, Wang Z. Eur J Radiol; 2009 Oct; 72(1):160-6. PubMed ID: 18707834 [Abstract] [Full Text] [Related]
4. Therapeutic effects and prognostic factors in high-intensity focused ultrasound combined with chemoembolisation for larger hepatocellular carcinoma. Li C, Zhang W, Zhang R, Zhang L, Wu P, Zhang F. Eur J Cancer; 2010 Sep; 46(13):2513-21. PubMed ID: 20663659 [Abstract] [Full Text] [Related]
5. High-intensity focused ultrasound for hepatocellular carcinoma: a single-center experience. Ng KK, Poon RT, Chan SC, Chok KS, Cheung TT, Tung H, Chu F, Tso WK, Yu WC, Lo CM, Fan ST. Ann Surg; 2011 May; 253(5):981-7. PubMed ID: 21394012 [Abstract] [Full Text] [Related]
6. High-intensity focused ultrasound combined with transarterial chemoembolization for unresectable hepatocellular carcinoma: long-term follow-up and clinical analysis. Jin C, Zhu H, Wang Z, Wu F, Chen W, Li K, Su H, Zhou K, Gong W. Eur J Radiol; 2011 Dec; 80(3):662-9. PubMed ID: 20864286 [Abstract] [Full Text] [Related]
7. [High intensity focused ultrasound therapy combined with transcatheter arterial chemoembolization for advanced hepatocellular carcinoma]. Jin CB, Wu F, Wang ZB, Chen WZ, Zhu H. Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):401-3. PubMed ID: 12921577 [Abstract] [Full Text] [Related]
8. Evaluation of short-term response of high intensity focused ultrasound ablation for primary hepatic carcinoma: utility of contrast-enhanced MRI and diffusion-weighted imaging. Zhang Y, Zhao J, Guo D, Zhong W, Ran L. Eur J Radiol; 2011 Sep; 79(3):347-52. PubMed ID: 20638211 [Abstract] [Full Text] [Related]
9. [Clinical observation on high intensity focused ultrasound combined with transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma]. Wu Y, Li J, Zhang SJ, Zhao YF, Zhao LS, Ma XX, Feng LS, Fan ZJ. Zhonghua Wai Ke Za Zhi; 2012 Aug; 50(8):691-4. PubMed ID: 23157899 [Abstract] [Full Text] [Related]
10. [The study of clinical application of high intensity focused ultrasound in non-invasive therapy for liver cancer]. Yi J, Li N, Jiang LS, Xiong XZ. Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 May; 36(3):426-8. PubMed ID: 15931887 [Abstract] [Full Text] [Related]
12. Survival analysis of high-intensity focused ultrasound therapy versus radiofrequency ablation in the treatment of recurrent hepatocellular carcinoma. Chan AC, Cheung TT, Fan ST, Chok KS, Chan SC, Poon RT, Lo CM. Ann Surg; 2013 Apr; 257(4):686-92. PubMed ID: 23426335 [Abstract] [Full Text] [Related]
13. [Clinical effect of transcatheter arterial chemoembolization combined with high intensity focused ultrasound ablation in treatment of large hepatocellular carcinoma]. Li CX, Wu PH, Fan WJ, Huang JH, Zhang FJ, Zhang L, Gu YK, Zhao M, Gao F, Jiao DC. Zhonghua Yi Xue Za Zhi; 2009 Mar 24; 89(11):754-7. PubMed ID: 19595104 [Abstract] [Full Text] [Related]
14. Prognostic factors for long-term outcome after percutaneous thermal ablation for hepatocellular carcinoma: a survival analysis of 137 consecutive patients. Xu HX, Lu MD, Xie XY, Yin XY, Kuang M, Chen JW, Xu ZF, Liu GJ. Clin Radiol; 2005 Sep 24; 60(9):1018-25. PubMed ID: 16124984 [Abstract] [Full Text] [Related]
17. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma. Li B, Yu J, Wang L, Li C, Zhou T, Zhai L, Xing L. Am J Clin Oncol; 2003 Aug 24; 26(4):e92-9. PubMed ID: 12902905 [Abstract] [Full Text] [Related]
18. Pilot study of high-intensity focused ultrasound ablation as a bridging therapy for hepatocellular carcinoma patients wait-listed for liver transplantation. Chok KS, Cheung TT, Lo RC, Chu FS, Tsang SH, Chan AC, Sharr WW, Fung JY, Dai WC, Chan SC, Fan ST, Lo CM. Liver Transpl; 2014 Aug 24; 20(8):912-21. PubMed ID: 24753206 [Abstract] [Full Text] [Related]
19. Evaluation of the therapeutic efficacy of high-intensity focused ultrasound ablation of hepatocellular carcinoma by three-dimensional sonography with a perflubutane-based contrast agent. Numata K, Fukuda H, Ohto M, Itou R, Nozaki A, Kondou M, Morimoto M, Karasawa E, Tanaka K. Eur J Radiol; 2010 Aug 24; 75(2):e67-75. PubMed ID: 20015603 [Abstract] [Full Text] [Related]
20. Extracorporeal high intensity focused ultrasound ablation in the treatment of patients with large hepatocellular carcinoma. Wu F, Wang ZB, Chen WZ, Zhu H, Bai J, Zou JZ, Li KQ, Jin CB, Xie FL, Su HB. Ann Surg Oncol; 2004 Dec 24; 11(12):1061-9. PubMed ID: 15545506 [Abstract] [Full Text] [Related] Page: [Next] [New Search]